News and Press Releases
Upperton Continues Strategic Growth with the Appointment of Michael Mellor-Clark as Chief Commercial Officer.
9 April 2025 – Nottingham, UK – Upperton Pharma Solutions, a leading UK-based contract development and manufacturing organisation (CDMO), continues its growth following the build of a new sterile manufacturing...
Category:
Posted: April 9, 2025
Albert Einstein Centre, Nottingham Science Park, Nottingham, UK, NG7 2TN
Sphere Fluidics strengthens global commercial teams and establishes direct sales and support channel in North America
Significant expansion of global commercial leadership team led by new CEO, Dale Levitzke, to address global demand for the Cyto-Mine Chroma platform 14 November 2024 – Cambridge, UK – Sphere...
Category: BioManufacturing
Posted: November 18, 2024
The Jonas Webb Building, Babraham Research Campus, Babraham, Cambridge CB22 3AT, United Kingdom
Seaport Therapeutics Names Lauren White as Chief Financial Officer
November 5, 2024 – Boston, MA, US – Seaport Therapeutics (“Seaport or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team,...
Category: Biotechnology
Posted: November 5, 2024
Hays appoints new Global Head of Life Sciences
18 October 2024 – London, UK – Hays, the global leader in workforce solutions and specialist recruitment, is pleased to announce the appointment of James Nyssen as Global Head of...
Category: Pharmaceutical
Posted: October 22, 2024
Sphere Fluidics awarded Gold accreditation by Investors in People
Internationally-recognized ‘We invest in people’ award is certified recognition of the Company’s care and commitment to its employees globally 14 June, 2024 - Cambridge, UK - Sphere Fluidics, a leading...
Category: Biotechnology, Drug Discovery
Posted: June 14, 2024
The Jonas Webb Building, Babraham Research Campus, Babraham, Cambridge CB22 3AT, United Kingdom
Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows
4 June 2024 - Cambridge, UK - Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the launch of Cyto-CellectPLUS. In conjunction with...
Category: Biotechnology, Drug Discovery
Posted: June 4, 2024
The Jonas Webb Building, Babraham Research Campus, Babraham, Cambridge CB22 3AT, United Kingdom
Asymchem welcomes Franck Mevellec as senior director of Business Development
29 May 2024 -- Paris, France -- Asymchem, a leading global CDMO, is excited to announce the appointment of Franck Mevellec as senior director of business development. Franck brings over...
Category: BioManufacturing, Drug Discovery, Pharmaceutical
Posted: May 29, 2024
Asymchem Laboratories (Tianjin) Co., Ltd No. 6 Dongting 3rd Avenue, TEDA Tianjin, 300457, P.R. China
Sphere Fluidics appoints Curtis Nicholson as director of Sales, EMEA, to support accelerated growth in key markets
23 May 2024 -- Cambridge, UK -- Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Curtis Nicholson as director...
Category: Biotechnology, Pharmaceutical
Posted: May 23, 2024
The Jonas Webb Building, Babraham Research Campus, Babraham, Cambridge CB22 3AT, United Kingdom
Closed Loop Medicine appoints Paul Johnson as Non-Executive Director
Appointment of digital healthcare leader to Board to support the company as it enters next phase of commercial development Co-founder and former CEO of Lemonaid Health, a leading innovator in...
Category: Biotechnology, Pharmaceutical
Posted: May 22, 2024
Babraham Research Campus Cambridge CB22 3AT United Kingdom
Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer
Dale Levitzke joins as Dr Frank F Craig, current CEO and co-founder, announces his retirement after leading the company for 14 years 30 April 2024 -- Cambridge, UK -- Sphere...
Category: Biotechnology, Other
Posted: April 30, 2024
The Jonas Webb Building, Babraham Research Campus, Babraham, Cambridge CB22 3AT, United Kingdom
X‑Chem Adds Chief Technology Officer to Bolster Its Digital Drug Discovery Strategy
2 April 2024 -- Massachusetts, US -- X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced the addition of Dr Erin Davis as chief technology officer....
Category: Drug Discovery
Posted: April 2, 2024
Arriello appoints experienced biotech expert, Kate Coleman, as VP of Quality & Compliance
The prestigious senior appointment comes as ambitious ATMP/innovative product companies continue to choose Arriello for holistic Regulatory/Quality services adapted to clients’ needs 20 September 2023 -- Dublin, Ireland --...
Category: Other
Posted: September 21, 2023
Phastar Appoints Graham Clark as New Chief Executive Officer
Phastar Sets Course for Further Growth with New CEO Appointment 10 August 2023 -- London, UK, and North Carolina, US -- Phastar, a global specialist biometrics contract research organisation (CRO),...
Category: Clinical Trials
Posted: August 17, 2023
